SPINEMarketGroup

CARLSBAD, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal surgery, today announced the issuance of its fourth U.S. patent related to Aurora’s proprietary DEXA Technology® platform. The newly issued patent, U.S. Patent No. 12,605,252 B2, titled … [Read More...] about Aurora Spine Announces Issuance of Fourth U.S. Patent Covering DEXA Technology® Bone Density-Matched Implants

First quarter 2026 revenue of $16.1 million, representing 58% growth year-over-year Full year 2026 revenue guidance raised to $72 million to $77 million CARLSBAD, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported financial results for the … [Read More...] about Carlsmed® Reports First Quarter 2026 Financial

CARLSBAD, Calif--(BUSINESS WIRE)-- Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended March 31, 2026, and business highlights. First Quarter 2026 Financial Results First Quarter Highlights “ATEC’s surgical … [Read More...] about ATEC Reports First Quarter Financial Results

DALLAS & LYON, France--(BUSINESS WIRE)--Regulatory News: SMAIO (Software, Machines and Adaptive Implants in Orthopaedics – Euronext Growth Paris, ISIN Code: FR0014005I80 / Ticker: ALSMA), a French-American company specialized in complex spine surgery and offering an integrated pre-, intra- and postoperative solution based on 3D planning software, adaptive implants and related services, … [Read More...] about SMAIO Announces that Portzamparc (BNP Paribas Group) has Initiated Coverage of its Stock with a Buy Rating

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the first quarter ended March 31, 2026, reflecting steady execution following recent spine commercial channel actions. Based on first-quarter performance, the Company reaffirmed its full-year 2026 financial guidance. All pro forma measures … [Read More...] about Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance

A new study published in Global Spine Journal, carried out by researchers from Johns Hopkins together with collaborators from the All India Institute of Medical Sciences (AIIMS) in New Delhi, has put an unusual detail on the radar of spine surgeons: the long-term use of inhaled corticosteroids in asthma patients. At first sight, this may sound like a minor point. Inhaled steroids are common, … [Read More...] about Inhaled Corticosteroids and Lumbar Fusion: A New Revision Risk Signal?

First-quarter 2026 revenue Spineway, a specialist in innovative implants for the treatment of severe spine disorders, recorded revenue of €2.2 million in the first quarter of 2026. Following strong growth in the fourth quarter of 2025 (+38%), the slowdown observed in the first quarter of 2026 will not undermine the Group’s momentum. It is mainly attributable to delays in regulatory … [Read More...] about Spineway : First-quarter 2026 revenue

FDA authorization marks critical milestone enabling advancement of next-generation bone regeneration therapy for patients with degenerative spinal diseases FREDERICK, Md., April 30, 2026 /PRNewswire/ -- Theradaptive, Inc., a clinical-stage biotechnology company pioneering targeted protein therapeutics for tissue regeneration, today announced that the U.S. Food and Drug … [Read More...] about Theradaptive Secures FDA Approval to Advance OASIS Trial to Pivotal Study Evaluating OsteoAdapt® SP in Spinal Fusion

MILAN, April 30, 2026 /PRNewswire/ -- Demetra, an innovative and independent international medical company leader providing bone cements, spacers and biomaterials for orthopedic, spine and neuro applications and orthopedic infection control, announces the successful completion of the acquisition of Maxxspine Innovative GmbH, a German-based company specialized in advanced spinal … [Read More...] about Demetra acquires Maxxspine Innovative GmbH, a company that has been a leader in advanced spinal solutions for over twenty years, further strengthening its position as a benchmark in spine surgery

New partnership-driven approach expands access to spine technology NEW YORK--(BUSINESS WIRE)--VB Spine LLC (“VB Spine”), today launched VB Spine Solutions, a program designed to bring critical spine technology to hospitals faster, with structures built around patient need. While focused on spine, VB Spine Solutions aligns with hospitals to simplify how capital equipment is placed, so … [Read More...] about VB Spine Announces VB Spine Solutions, a Partnership-Driven Program to Help Hospitals Acquire Technology